| Period Ending | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 |
|---|
|
Total Revenue
|
11,010,000
|
10,671,000
|
11,737,000
|
11,489,000
| | Cost of Revenue | 4,284,000 | 3,959,000 | 4,160,000 | 4,136,000 | | |
Gross Profit
|
6,726,000
|
6,712,000
|
7,577,000
|
7,353,000
| |
|
Operating Expenses |
|
Research Development | 2,101,000 | 1,907,000 | 2,224,000 | 1,918,000 |
|
Selling General and Administrative | 3,139,000 | 2,987,000 | 3,390,000 | 3,064,000 |
|
Non Recurring | 155,000 | 119,000 | 191,000 | 110,000 |
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
1,331,000
|
1,699,000
|
1,772,000
|
2,261,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (202,000) | (282,000) | (670,000) | (199,000) |
|
Earnings Before Interest And Taxes | 1,245,000 | 1,550,000 | 1,334,000 | 2,219,000 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 1,245,000 | 1,550,000 | 1,334,000 | 2,219,000 |
|
Income Tax Expense | 310,000 | (66,000) | 385,000 | 456,000 |
|
Minority Interest | (29,000) | (23,000) | (42,000) | (33,000) |
|
|
|
Net Income From Continuing Ops | 1,022,000 | 1,726,000 | 1,139,000 | 1,887,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
906,000
|
1,593,000
|
907,000
|
1,730,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
906,000
|
1,593,000
|
907,000
|
1,730,000
|
|
0.41%